Article info
Oncology
Likelihood of germline mutation with solitary retinoblastoma based on tumour location at presentation
- Correspondence to Dr Carol L Shields, Oncology Service, Wills Eye Hospital, Philadelphia, Pennsylvania, USA; carolshields{at}gmail.com
Citation
Likelihood of germline mutation with solitary retinoblastoma based on tumour location at presentation
Publication history
- Received July 6, 2022
- Accepted November 7, 2022
- First published November 22, 2022.
Online issue publication
December 18, 2023
Article Versions
- Previous version (18 December 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.